Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies
Background Controlled human malaria infection (CHMI) studies increasingly rely on nucleic acid test (NAT) methods to detect and quantify parasites in the blood of infected participants. The lower limits of detection and quantification vary amongst the assays used throughout the world, which may affe...
Saved in:
| Published in | Malaria journal Vol. 14; no. 1; p. 33 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
28.01.2015
BioMed Central Ltd |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1475-2875 1475-2875 |
| DOI | 10.1186/s12936-015-0541-6 |
Cover
| Abstract | Background
Controlled human malaria infection (CHMI) studies increasingly rely on nucleic acid test (NAT) methods to detect and quantify parasites in the blood of infected participants. The lower limits of detection and quantification vary amongst the assays used throughout the world, which may affect the ability of mathematical models to accurately estimate the liver-to-blood inoculum (LBI) values that are used to judge the efficacy of pre-erythrocytic vaccine and drug candidates.
Methods
Samples were collected around the time of onset of pre-patent parasitaemia from subjects who enrolled in two different CHMI clinical trials. Blood samples were tested for
Plasmodium falciparum
18S rRNA and/or rDNA targets by different NAT methods and results were compared. Methods included an ultrasensitive, large volume modification of an established quantitative reverse transcription PCR (qRT-PCR) assay that achieves detection of as little as one parasite/mL of whole blood.
Results
Large volume qRT-PCR at the University of Washington was the most sensitive test and generated quantifiable data more often than any other NAT methodology. Standard quantitative PCR (qPCR) performed at the University of Oxford and standard volume qRT-PCR performed at the University of Washington were less sensitive than the large volume qRT-PCR, especially at 6.5 days after CHMI. In these trials, the proportion of participants for whom LBI could be accurately quantified using parasite density value greater than or equal to the lower limit of quantification was increased. A greater improvement would be expected in trials in which numerous subjects receive a lower LBI or low dose challenge.
Conclusions
Standard qPCR and qRT-PCR methods with analytical sensitivities of ~20 parasites/mL probably suffice for most CHMI purposes, but the newly developed large volume qRT-PCR may be able to answer specific questions when more analytical sensitivity is required. |
|---|---|
| AbstractList | Controlled human malaria infection (CHMI) studies increasingly rely on nucleic acid test (NAT) methods to detect and quantify parasites in the blood of infected participants. The lower limits of detection and quantification vary amongst the assays used throughout the world, which may affect the ability of mathematical models to accurately estimate the liver-to-blood inoculum (LBI) values that are used to judge the efficacy of pre-erythrocytic vaccine and drug candidates. Large volume qRT-PCR at the University of Washington was the most sensitive test and generated quantifiable data more often than any other NAT methodology. Standard quantitative PCR (qPCR) performed at the University of Oxford and standard volume qRT-PCR performed at the University of Washington were less sensitive than the large volume qRT-PCR, especially at 6.5 days after CHMI. In these trials, the proportion of participants for whom LBI could be accurately quantified using parasite density value greater than or equal to the lower limit of quantification was increased. A greater improvement would be expected in trials in which numerous subjects receive a lower LBI or low dose challenge. Standard qPCR and qRT-PCR methods with analytical sensitivities of ~20 parasites/mL probably suffice for most CHMI purposes, but the newly developed large volume qRT-PCR may be able to answer specific questions when more analytical sensitivity is required. Controlled human malaria infection (CHMI) studies increasingly rely on nucleic acid test (NAT) methods to detect and quantify parasites in the blood of infected participants. The lower limits of detection and quantification vary amongst the assays used throughout the world, which may affect the ability of mathematical models to accurately estimate the liver-to-blood inoculum (LBI) values that are used to judge the efficacy of pre-erythrocytic vaccine and drug candidates.BACKGROUNDControlled human malaria infection (CHMI) studies increasingly rely on nucleic acid test (NAT) methods to detect and quantify parasites in the blood of infected participants. The lower limits of detection and quantification vary amongst the assays used throughout the world, which may affect the ability of mathematical models to accurately estimate the liver-to-blood inoculum (LBI) values that are used to judge the efficacy of pre-erythrocytic vaccine and drug candidates.Samples were collected around the time of onset of pre-patent parasitaemia from subjects who enrolled in two different CHMI clinical trials. Blood samples were tested for Plasmodium falciparum 18S rRNA and/or rDNA targets by different NAT methods and results were compared. Methods included an ultrasensitive, large volume modification of an established quantitative reverse transcription PCR (qRT-PCR) assay that achieves detection of as little as one parasite/mL of whole blood.METHODSSamples were collected around the time of onset of pre-patent parasitaemia from subjects who enrolled in two different CHMI clinical trials. Blood samples were tested for Plasmodium falciparum 18S rRNA and/or rDNA targets by different NAT methods and results were compared. Methods included an ultrasensitive, large volume modification of an established quantitative reverse transcription PCR (qRT-PCR) assay that achieves detection of as little as one parasite/mL of whole blood.Large volume qRT-PCR at the University of Washington was the most sensitive test and generated quantifiable data more often than any other NAT methodology. Standard quantitative PCR (qPCR) performed at the University of Oxford and standard volume qRT-PCR performed at the University of Washington were less sensitive than the large volume qRT-PCR, especially at 6.5 days after CHMI. In these trials, the proportion of participants for whom LBI could be accurately quantified using parasite density value greater than or equal to the lower limit of quantification was increased. A greater improvement would be expected in trials in which numerous subjects receive a lower LBI or low dose challenge.RESULTSLarge volume qRT-PCR at the University of Washington was the most sensitive test and generated quantifiable data more often than any other NAT methodology. Standard quantitative PCR (qPCR) performed at the University of Oxford and standard volume qRT-PCR performed at the University of Washington were less sensitive than the large volume qRT-PCR, especially at 6.5 days after CHMI. In these trials, the proportion of participants for whom LBI could be accurately quantified using parasite density value greater than or equal to the lower limit of quantification was increased. A greater improvement would be expected in trials in which numerous subjects receive a lower LBI or low dose challenge.Standard qPCR and qRT-PCR methods with analytical sensitivities of ~20 parasites/mL probably suffice for most CHMI purposes, but the newly developed large volume qRT-PCR may be able to answer specific questions when more analytical sensitivity is required.CONCLUSIONSStandard qPCR and qRT-PCR methods with analytical sensitivities of ~20 parasites/mL probably suffice for most CHMI purposes, but the newly developed large volume qRT-PCR may be able to answer specific questions when more analytical sensitivity is required. Controlled human malaria infection (CHMI) studies increasingly rely on nucleic acid test (NAT) methods to detect and quantify parasites in the blood of infected participants. The lower limits of detection and quantification vary amongst the assays used throughout the world, which may affect the ability of mathematical models to accurately estimate the liver-to-blood inoculum (LBI) values that are used to judge the efficacy of pre-erythrocytic vaccine and drug candidates. Samples were collected around the time of onset of pre-patent parasitaemia from subjects who enrolled in two different CHMI clinical trials. Blood samples were tested for Plasmodium falciparum 18S rRNA and/or rDNA targets by different NAT methods and results were compared. Methods included an ultrasensitive, large volume modification of an established quantitative reverse transcription PCR (qRT-PCR) assay that achieves detection of as little as one parasite/mL of whole blood. Large volume qRT-PCR at the University of Washington was the most sensitive test and generated quantifiable data more often than any other NAT methodology. Standard quantitative PCR (qPCR) performed at the University of Oxford and standard volume qRT-PCR performed at the University of Washington were less sensitive than the large volume qRT-PCR, especially at 6.5 days after CHMI. In these trials, the proportion of participants for whom LBI could be accurately quantified using parasite density value greater than or equal to the lower limit of quantification was increased. A greater improvement would be expected in trials in which numerous subjects receive a lower LBI or low dose challenge. Standard qPCR and qRT-PCR methods with analytical sensitivities of ~20 parasites/mL probably suffice for most CHMI purposes, but the newly developed large volume qRT-PCR may be able to answer specific questions when more analytical sensitivity is required. Background Controlled human malaria infection (CHMI) studies increasingly rely on nucleic acid test (NAT) methods to detect and quantify parasites in the blood of infected participants. The lower limits of detection and quantification vary amongst the assays used throughout the world, which may affect the ability of mathematical models to accurately estimate the liver-to-blood inoculum (LBI) values that are used to judge the efficacy of pre-erythrocytic vaccine and drug candidates. Methods Samples were collected around the time of onset of pre-patent parasitaemia from subjects who enrolled in two different CHMI clinical trials. Blood samples were tested for Plasmodium falciparum 18S rRNA and/or rDNA targets by different NAT methods and results were compared. Methods included an ultrasensitive, large volume modification of an established quantitative reverse transcription PCR (qRT-PCR) assay that achieves detection of as little as one parasite/mL of whole blood. Results Large volume qRT-PCR at the University of Washington was the most sensitive test and generated quantifiable data more often than any other NAT methodology. Standard quantitative PCR (qPCR) performed at the University of Oxford and standard volume qRT-PCR performed at the University of Washington were less sensitive than the large volume qRT-PCR, especially at 6.5 days after CHMI. In these trials, the proportion of participants for whom LBI could be accurately quantified using parasite density value greater than or equal to the lower limit of quantification was increased. A greater improvement would be expected in trials in which numerous subjects receive a lower LBI or low dose challenge. Conclusions Standard qPCR and qRT-PCR methods with analytical sensitivities of ~20 parasites/mL probably suffice for most CHMI purposes, but the newly developed large volume qRT-PCR may be able to answer specific questions when more analytical sensitivity is required. Keywords: Plasmodium falciparum, 18S rRNA, PCR, RT-PCR, Standards, Controls, Calibrators, Pre-erythrocytic Background Controlled human malaria infection (CHMI) studies increasingly rely on nucleic acid test (NAT) methods to detect and quantify parasites in the blood of infected participants. The lower limits of detection and quantification vary amongst the assays used throughout the world, which may affect the ability of mathematical models to accurately estimate the liver-to-blood inoculum (LBI) values that are used to judge the efficacy of pre-erythrocytic vaccine and drug candidates. Methods Samples were collected around the time of onset of pre-patent parasitaemia from subjects who enrolled in two different CHMI clinical trials. Blood samples were tested for Plasmodium falciparum 18S rRNA and/or rDNA targets by different NAT methods and results were compared. Methods included an ultrasensitive, large volume modification of an established quantitative reverse transcription PCR (qRT-PCR) assay that achieves detection of as little as one parasite/mL of whole blood. Results Large volume qRT-PCR at the University of Washington was the most sensitive test and generated quantifiable data more often than any other NAT methodology. Standard quantitative PCR (qPCR) performed at the University of Oxford and standard volume qRT-PCR performed at the University of Washington were less sensitive than the large volume qRT-PCR, especially at 6.5 days after CHMI. In these trials, the proportion of participants for whom LBI could be accurately quantified using parasite density value greater than or equal to the lower limit of quantification was increased. A greater improvement would be expected in trials in which numerous subjects receive a lower LBI or low dose challenge. Conclusions Standard qPCR and qRT-PCR methods with analytical sensitivities of ~20 parasites/mL probably suffice for most CHMI purposes, but the newly developed large volume qRT-PCR may be able to answer specific questions when more analytical sensitivity is required. Background: Controlled human malaria infection (CHMI) studies increasingly rely on nucleic acid test (NAT) methods to detect and quantify parasites in the blood of infected participants. The lower limits of detection and quantification vary amongst the assays used throughout the world, which may affect the ability of mathematical models to accurately estimate the liver-to-blood inoculum (LBI) values that are used to judge the efficacy of pre-erythrocytic vaccine and drug candidates. Methods: Samples were collected around the time of onset of pre-patent parasitaemia from subjects who enrolled in two different CHMI clinical trials. Blood samples were tested for Plasmodium falciparum 18S rRNA and/or rDNA targets by different NAT methods and results were compared. Methods included an ultrasensitive, large volume modification of an established quantitative reverse transcription PCR (qRT-PCR) assay that achieves detection of as little as one parasite/mL of whole blood. Results: Large volume qRT-PCR at the University of Washington was the most sensitive test and generated quantifiable data more often than any other NAT methodology. Standard quantitative PCR (qPCR) performed at the University of Oxford and standard volume qRT-PCR performed at the University of Washington were less sensitive than the large volume qRT-PCR, especially at 6.5 days after CHMI. In these trials, the proportion of participants for whom LBI could be accurately quantified using parasite density value greater than or equal to the lower limit of quantification was increased. A greater improvement would be expected in trials in which numerous subjects receive a lower LBI or low dose challenge. Conclusions: Standard qPCR and qRT-PCR methods with analytical sensitivities of 20 parasites/mL probably suffice for most CHMI purposes, but the newly developed large volume qRT-PCR may be able to answer specific questions when more analytical sensitivity is required. |
| ArticleNumber | 33 |
| Audience | Academic |
| Author | Chang, Ming Muia, Alfred Magiri, Charles Gilbert, Sarah C Hodgson, Susanne H Kimani, Domtila Draper, Simon J Bejon, Philip Ogutu, Bernhards Anagnostou, Nicholas A Murphy, Sean C Seilie, Annette M Daza, Glenda Elias, Sean C Douglas, Alexander D Hill, Adrian VS Edwards, Nick J Marsh, Kevin Cole, Andrew O Rampling, Thomas W Juma, Elizabeth A Hoffman, Stephen L |
| Author_xml | – sequence: 1 givenname: Susanne H surname: Hodgson fullname: Hodgson, Susanne H organization: The Jenner Institute, University of Oxford – sequence: 2 givenname: Alexander D surname: Douglas fullname: Douglas, Alexander D organization: The Jenner Institute, University of Oxford – sequence: 3 givenname: Nick J surname: Edwards fullname: Edwards, Nick J organization: The Jenner Institute, University of Oxford – sequence: 4 givenname: Domtila surname: Kimani fullname: Kimani, Domtila organization: Kenya Medical Research Institute - Wellcome Trust, Centre for Geographical Medical Research (Coast) – sequence: 5 givenname: Sean C surname: Elias fullname: Elias, Sean C organization: The Jenner Institute, University of Oxford – sequence: 6 givenname: Ming surname: Chang fullname: Chang, Ming organization: Department of Laboratory Medicine and Center for Emerging and Re-Emerging Infectious Diseases, University of Washington (UW) – sequence: 7 givenname: Glenda surname: Daza fullname: Daza, Glenda organization: Department of Laboratory Medicine and Center for Emerging and Re-Emerging Infectious Diseases, University of Washington (UW) – sequence: 8 givenname: Annette M surname: Seilie fullname: Seilie, Annette M organization: Department of Laboratory Medicine and Center for Emerging and Re-Emerging Infectious Diseases, University of Washington (UW) – sequence: 9 givenname: Charles surname: Magiri fullname: Magiri, Charles organization: Centre for Clinical Research, Kenya Medical Research Institute – sequence: 10 givenname: Alfred surname: Muia fullname: Muia, Alfred organization: Centre for Clinical Research, Kenya Medical Research Institute – sequence: 11 givenname: Elizabeth A surname: Juma fullname: Juma, Elizabeth A organization: Centre for Clinical Research, Kenya Medical Research Institute, Centre for Research in Therapeutic Sciences, Strathmore University – sequence: 12 givenname: Andrew O surname: Cole fullname: Cole, Andrew O organization: Centre for Clinical Research, Kenya Medical Research Institute – sequence: 13 givenname: Thomas W surname: Rampling fullname: Rampling, Thomas W organization: The Jenner Institute, University of Oxford – sequence: 14 givenname: Nicholas A surname: Anagnostou fullname: Anagnostou, Nicholas A organization: The Jenner Institute, University of Oxford – sequence: 15 givenname: Sarah C surname: Gilbert fullname: Gilbert, Sarah C organization: The Jenner Institute, University of Oxford – sequence: 16 givenname: Stephen L surname: Hoffman fullname: Hoffman, Stephen L organization: Sanaria, Inc – sequence: 17 givenname: Simon J surname: Draper fullname: Draper, Simon J organization: The Jenner Institute, University of Oxford – sequence: 18 givenname: Philip surname: Bejon fullname: Bejon, Philip organization: Kenya Medical Research Institute - Wellcome Trust, Centre for Geographical Medical Research (Coast) – sequence: 19 givenname: Bernhards surname: Ogutu fullname: Ogutu, Bernhards organization: Centre for Clinical Research, Kenya Medical Research Institute, Centre for Research in Therapeutic Sciences, Strathmore University – sequence: 20 givenname: Kevin surname: Marsh fullname: Marsh, Kevin organization: Kenya Medical Research Institute - Wellcome Trust, Centre for Geographical Medical Research (Coast) – sequence: 21 givenname: Adrian VS surname: Hill fullname: Hill, Adrian VS organization: The Jenner Institute, University of Oxford – sequence: 22 givenname: Sean C surname: Murphy fullname: Murphy, Sean C email: murphysc@uw.edu organization: Department of Laboratory Medicine and Center for Emerging and Re-Emerging Infectious Diseases, University of Washington (UW) |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25627033$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNks1u1DAUhSNURH_gAdggS2zYpNiJHTsbpGpES6VKIARry-PcTF05dmonI8FD8YzcmbSoRahCWSTx_c65vvY5Lg5CDFAUrxk9ZUw17zOr2ropKRMlFZyVzbPiiHEpykpJcfDg-7A4zvmGUiaVrF4Uh5VoKknr-qj4dRlsApOhI9kMoweyjX4egJjQkTkDiT25nU2Y3GQmtwWSYAspQzklE7JNbpxcDOTL6iuxJhA3jCkiNSbonN2X0MCjMJVTLNc-xo64EO2MTUh2PwH_iI1hStF73MT1PKDNYLxJzmCth8UlT3PnIL8snvfGZ3h19z4pvp9__Lb6VF59vrhcnV2VVvBqKpv1uue257LFMYF2tBbQmcZWqgJh6dpyK1XNhKRt26qKG9oJ7NQIrCtcrE-KD4vvOK8H6CzgBo3XY3KDST90NE4_rgR3rTdxq3nNFGsFGry7M0jxdoY86cFlC96bAHHOmjWSN0ox0f4H2lCOnkwh-nZBN8aDxtOJ2NzucH2GAeCyVvvep_-g8OlgcHjW0DtcfyR483DaP2PexwQBuQA2xZwT9Nru87C7N-O8ZlTvAqmXQGoMpN4FUjeoZH8p782f0lSLJiMbNpD0TZxTwPt-QvQbEOD12g |
| CitedBy_id | crossref_primary_10_1186_s12936_018_2422_2 crossref_primary_10_1128_JCM_00948_18 crossref_primary_10_1016_j_diagmicrobio_2016_11_021 crossref_primary_10_1016_j_micpath_2015_08_015 crossref_primary_10_1016_j_vaccine_2017_10_093 crossref_primary_10_1038_s41541_017_0028_2 crossref_primary_10_1016_j_isci_2022_104224 crossref_primary_10_1016_j_pt_2021_05_001 crossref_primary_10_1186_s12936_025_05282_0 crossref_primary_10_1016_j_microc_2023_109516 crossref_primary_10_1186_s12936_015_1051_2 crossref_primary_10_4269_ajtmh_21_1226 crossref_primary_10_1172_jci_insight_146443 crossref_primary_10_1016_j_vaccine_2015_07_107 crossref_primary_10_1016_j_omtm_2022_07_016 crossref_primary_10_1371_journal_pone_0165506 crossref_primary_10_1016_j_vaccine_2015_09_074 crossref_primary_10_1186_s12879_015_1070_1 crossref_primary_10_7554_eLife_83874 crossref_primary_10_1186_s12936_020_03200_0 crossref_primary_10_1186_s13071_023_05904_z crossref_primary_10_3109_10408363_2015_1084991 crossref_primary_10_1093_ofid_ofad202 crossref_primary_10_4269_ajtmh_17_0343 crossref_primary_10_1021_acs_analchem_6b01485 crossref_primary_10_1172_jci_insight_135589 crossref_primary_10_4049_jimmunol_1800740 crossref_primary_10_1186_s12936_020_03177_w crossref_primary_10_1128_JCM_01879_19 crossref_primary_10_1186_s12936_022_04103_y crossref_primary_10_1016_j_parepi_2017_04_001 |
| Cites_doi | 10.4161/hv.25383 10.1093/infdis/jit156 10.1371/journal.pone.0065960 10.1371/journal.pone.0038434 10.4269/ajtmh.2005.73.191 10.1038/nm881 10.1186/1475-2875-13-288 10.1128/JCM.41.10.4531-4536.2003 10.1128/JCM.02549-12 10.1086/427243 10.4269/ajtmh.2012.10-0658 10.4269/ajtmh.2013.12-0715 10.1371/journal.pone.0097398 10.4269/ajtmh.14-0119 10.1007/s11904-011-0104-6 10.1128/jcm.27.7.1434-1437.1989 10.1016/j.vaccine.2004.08.020 10.1016/0035-9203(47)90025-4 10.1093/infdis/jis355 10.1038/nri2902 10.4269/ajtmh.2012.12-0613 10.3389/fmicb.2014.00686 |
| ContentType | Journal Article |
| Copyright | Hodgson et al.; licensee Biomed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( ) applies to the data made available in this article, unless otherwise stated. COPYRIGHT 2015 BioMed Central Ltd. Hodgson et al.; licensee Biomed Central. 2015 |
| Copyright_xml | – notice: Hodgson et al.; licensee Biomed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( ) applies to the data made available in this article, unless otherwise stated. – notice: COPYRIGHT 2015 BioMed Central Ltd. – notice: Hodgson et al.; licensee Biomed Central. 2015 |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T2 7TM C1K F1W H95 H97 L.G M7N 7X8 5PM |
| DOI | 10.1186/s12936-015-0541-6 |
| DatabaseName | Open Access资源_Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Health and Safety Science Abstracts (Full archive) Nucleic Acids Abstracts Environmental Sciences and Pollution Management ASFA: Aquatic Sciences and Fisheries Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality Aquatic Science & Fisheries Abstracts (ASFA) Professional Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Aquatic Science & Fisheries Abstracts (ASFA) Professional Algology Mycology and Protozoology Abstracts (Microbiology C) Nucleic Acids Abstracts ASFA: Aquatic Sciences and Fisheries Abstracts Health & Safety Science Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Aquatic Science & Fisheries Abstracts (ASFA) Professional |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health |
| EISSN | 1475-2875 |
| EndPage | 33 |
| ExternalDocumentID | PMC4318195 A541473895 25627033 10_1186_s12936_015_0541_6 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | Kenya |
| GeographicLocations_xml | – name: Kenya |
| GrantInformation_xml | – fundername: NIAID NIH HHS grantid: K08 AI097238 – fundername: Wellcome Trust grantid: 092654 – fundername: Wellcome Trust grantid: 45488/Z/05 – fundername: NIAID NIH HHS grantid: K08AI097238 – fundername: NIAID NIH HHS grantid: R44AI058375 – fundername: Medical Research Council grantid: G1002624 – fundername: Medical Research Council grantid: G1000527 – fundername: NIAID NIH HHS grantid: R44 AI058375 – fundername: Wellcome Trust grantid: 097940/Z/11/Z – fundername: NIAID NIH HHS grantid: P30 AI027757 |
| GroupedDBID | --- 0R~ 29M 2WC 4.4 53G 5VS 7X7 88E 8C1 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS ECGQY EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR IPNFZ ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RIG RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 7T2 7TM C1K F1W H95 H97 L.G M7N 7X8 5PM |
| ID | FETCH-LOGICAL-c542t-6bbf4cf479270e0d035eda6c282e5c0bc4c7831570999824a0d5fec6582e87093 |
| IEDL.DBID | M48 |
| ISSN | 1475-2875 |
| IngestDate | Thu Aug 21 14:13:13 EDT 2025 Fri Sep 05 13:46:47 EDT 2025 Fri Sep 05 12:30:01 EDT 2025 Tue Jun 17 22:05:27 EDT 2025 Tue Jun 10 21:10:04 EDT 2025 Mon Jul 21 05:49:20 EDT 2025 Thu Apr 24 23:12:31 EDT 2025 Tue Jul 01 02:39:41 EDT 2025 Sat Sep 06 07:29:35 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Calibrators Pre-erythrocytic RT-PCR 18S rRNA Controls PCR Standards |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c542t-6bbf4cf479270e0d035eda6c282e5c0bc4c7831570999824a0d5fec6582e87093 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12936-015-0541-6 |
| PMID | 25627033 |
| PQID | 1660419518 |
| PQPubID | 23462 |
| PageCount | 1 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4318195 proquest_miscellaneous_1674688159 proquest_miscellaneous_1660419518 gale_infotracmisc_A541473895 gale_infotracacademiconefile_A541473895 pubmed_primary_25627033 crossref_citationtrail_10_1186_s12936_015_0541_6 crossref_primary_10_1186_s12936_015_0541_6 springer_journals_10_1186_s12936_015_0541_6 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2015-01-28 |
| PublicationDateYYYYMMDD | 2015-01-28 |
| PublicationDate_xml | – month: 01 year: 2015 text: 2015-01-28 day: 28 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Malaria journal |
| PublicationTitleAbbrev | Malar J |
| PublicationTitleAlternate | Malar J |
| PublicationYear | 2015 |
| Publisher | BioMed Central BioMed Central Ltd |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd |
| References | AD Douglas (541_CR11) 2013; 208 SH Sheehy (541_CR9) 2013; 8 NH Fairley (541_CR13) 1947; 40 SC Murphy (541_CR14) 2012; 50 JR Murphy (541_CR12) 1989; 27 SC Murphy (541_CR6) 2012; 86 SJ McConkey (541_CR19) 2003; 9 M Roestenberg (541_CR2) 2012; 206 BB Hilldorfer (541_CR22) 2012; 9 M Roestenberg (541_CR7) 2012; 7 L Andrews (541_CR17) 2005; 73 SH Sheehy (541_CR4) 2013; 9 RW Sauerwein (541_CR1) 2011; 11 S Palmer (541_CR21) 2003; 41 541_CR15 P Bejon (541_CR18) 2005; 191 S Shekalaghe (541_CR16) 2014; 91 SC Murphy (541_CR5) 2014; 9 JE Epstein (541_CR3) 2013; 88 M Roestenberg (541_CR8) 2013; 88 E Kamau (541_CR10) 2014; 13 M Walther (541_CR20) 2005; 23 |
| References_xml | – volume: 9 start-page: 1831 year: 2013 ident: 541_CR4 publication-title: Hum Vaccin Immunother doi: 10.4161/hv.25383 – volume: 208 start-page: 340 year: 2013 ident: 541_CR11 publication-title: J Infect Dis doi: 10.1093/infdis/jit156 – volume: 8 start-page: e65960 year: 2013 ident: 541_CR9 publication-title: PLoS One doi: 10.1371/journal.pone.0065960 – volume: 7 start-page: e38434 year: 2012 ident: 541_CR7 publication-title: PLoS One doi: 10.1371/journal.pone.0038434 – volume: 73 start-page: 191 year: 2005 ident: 541_CR17 publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.2005.73.191 – volume: 9 start-page: 729 year: 2003 ident: 541_CR19 publication-title: Nat Med doi: 10.1038/nm881 – volume: 13 start-page: 288 year: 2014 ident: 541_CR10 publication-title: Malar J doi: 10.1186/1475-2875-13-288 – volume: 41 start-page: 4531 year: 2003 ident: 541_CR21 publication-title: J Clin Microbiol doi: 10.1128/JCM.41.10.4531-4536.2003 – volume: 50 start-page: 4128 year: 2012 ident: 541_CR14 publication-title: J Clin Microbiol doi: 10.1128/JCM.02549-12 – volume: 191 start-page: 619 year: 2005 ident: 541_CR18 publication-title: J Infect Dis doi: 10.1086/427243 – volume: 86 start-page: 383 year: 2012 ident: 541_CR6 publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.2012.10-0658 – volume: 88 start-page: 3 year: 2013 ident: 541_CR3 publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.2013.12-0715 – volume: 9 start-page: e97398 year: 2014 ident: 541_CR5 publication-title: PLoS One doi: 10.1371/journal.pone.0097398 – volume: 91 start-page: 471 year: 2014 ident: 541_CR16 publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.14-0119 – volume: 9 start-page: 91 year: 2012 ident: 541_CR22 publication-title: Curr HIV/AIDS Rep doi: 10.1007/s11904-011-0104-6 – volume: 27 start-page: 1434 year: 1989 ident: 541_CR12 publication-title: J Clin Microbiol doi: 10.1128/jcm.27.7.1434-1437.1989 – volume: 23 start-page: 857 year: 2005 ident: 541_CR20 publication-title: Vaccine doi: 10.1016/j.vaccine.2004.08.020 – volume: 40 start-page: 621 year: 1947 ident: 541_CR13 publication-title: Trans R Soc Trop Med Hyg doi: 10.1016/0035-9203(47)90025-4 – volume: 206 start-page: 319 year: 2012 ident: 541_CR2 publication-title: J Infect Dis doi: 10.1093/infdis/jis355 – volume: 11 start-page: 57 year: 2011 ident: 541_CR1 publication-title: Nat Rev Immunol doi: 10.1038/nri2902 – volume: 88 start-page: 5 year: 2013 ident: 541_CR8 publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.2012.12-0613 – ident: 541_CR15 doi: 10.3389/fmicb.2014.00686 |
| SSID | ssj0017872 |
| Score | 2.2754014 |
| Snippet | Background
Controlled human malaria infection (CHMI) studies increasingly rely on nucleic acid test (NAT) methods to detect and quantify parasites in the blood... Controlled human malaria infection (CHMI) studies increasingly rely on nucleic acid test (NAT) methods to detect and quantify parasites in the blood of... Background Controlled human malaria infection (CHMI) studies increasingly rely on nucleic acid test (NAT) methods to detect and quantify parasites in the blood... Background: Controlled human malaria infection (CHMI) studies increasingly rely on nucleic acid test (NAT) methods to detect and quantify parasites in the... |
| SourceID | pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 33 |
| SubjectTerms | Adult Biomedical and Life Sciences Biomedicine DNA, Protozoan - blood Entomology Female Humans Infectious Diseases Limit of Detection Malaria - diagnosis Malaria - epidemiology Malaria - parasitology Male Microbiology Middle Aged Molecular Diagnostic Techniques Parasitemia - diagnosis Parasitemia - parasitology Parasitology Plasmodium falciparum Polymerase Chain Reaction - methods Public Health RNA, Ribosomal, 18S - genetics Tropical Medicine Young Adult |
| SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEA96vggifls9ZQRBUIJtmqTZx-XwOARFxIV7C2ma4sJee267L_5R9zfeTNoudtEDH0vSEDJfv8lMZhh769CKIorwXJRCcelRFEunAi9yqQxadCljt4YvX_XZSn4-V-fjO-5uynafQpJRU0exNvpjR5aJvF_FEWZkXN9mdxS67iSNK7Hchw6QA8UYvvzrbzMDdKiG_7BDhzmSB4HSaH9OH7D7I3CE5UDph-xWaB6xe8OtGwyPiR6zKxR3yjIPFXSO6v7CoH3ANRXsugBtDb92rokvy1DPARVw2naB92SyJgUC306-Ax45rOONQ4DLLYVz4hAusKFUDt63PCa9w7pp4xUidOvfAb9gzH7f4CZiB0C4cOg-rx1MiV8NdEP24hO2Ov304-SMjx0ZuFdS9FyXZS19LYuFKNKQVmmuQuW0R78tKJ-WXvrC5JkqCHcaIV1aKVwZUY4IqBgW-VN21LRNeM6gqhGslLhEKJSsanTEK5dp7xbO6LxapAlLJzJZP5Yrp64ZGxvdFqPtQFmLlLVEWasT9n7_y-VQq-Omye-I9pbkGNf1bnyOgLujilh2Sf3RC4RzKmHHs5kof342_GbiHktDlLTWhHbX2UzrVGbI8OamOYXUxiCoTNizgeP2e0c0isec5wkrZry4n0ClwecjzfpnLBGOsJACpAn7MHGtHXVT9-8jefFfs1-yuyJKVcaFOWZH_XYXXiFA68vXUSCvAWQ8Nyo priority: 102 providerName: Springer Nature |
| Title | Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies |
| URI | https://link.springer.com/article/10.1186/s12936-015-0541-6 https://www.ncbi.nlm.nih.gov/pubmed/25627033 https://www.proquest.com/docview/1660419518 https://www.proquest.com/docview/1674688159 https://pubmed.ncbi.nlm.nih.gov/PMC4318195 |
| Volume | 14 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dixMxEB_u40UQ8dvVs0QQBCW6H0k2fRCp5Y6jcMdxWri3kM2mXKFu77otqH-Uf6Mz2d1qy3kPvmxpk01D5us3yWQG4LVFK4oowvG0SCUXDkWxsNLzPBNSo0UXIlRrODlVx2MxupAXO9CVt2oXsL7RtaN6UuPF7P336x-fUOA_BoHX6kNNNov8YskRgCRc7cI-GiZFvtiJ-HOogLyZtgebN75GiYERDqAMZBtWaltX_2WstgMpt05Tg5E6ug_3WnTJBg07PIAdXz2Eu83WHGtuHD2CX6gTKBTdl6y2lByYNSqK2apkq9qz-YRdr2wVrp-hMmSU5WlRe74ku9ZpGXY2PGdIFzYN2xKeXS3ozCc04QAzivfgyzkPkfFsWs3DPiOrpz89fmNtiPwMJxHKBLJvFgkxtayLDqtY3YQ4Pobx0eHX4TFvyzZwJ0W65KooJsJNRN7HpfRxGWfSl1Y5dO68dHHhhMt1lsicwKlOhY1LiSMjFEo9ao9-9gT2qnnlnwErJ4hoChzC51KUE_TWS5soZ_tWq6zsxxHEHZmMa3OaU2mNmQm-jVamIbJBIhsislERvF2_ctUk9Lit8xuivSH2w3Gdbe8s4OwobZYZUBH1HDGfjOBgoycKqdtoftVxj6Emimyr_HxVm0SpWCQoFfq2PrlQWiPyjOBpw3HruXccG0G-wYvrDpQ_fLOlml6GPOKIHekUNYJ3HdeaTv7-vSTP__t_XsCdNAhbwlN9AHvLxcq_RES3LHqwm1_k-NTDpAf7g8Hoywg_Px-enp3jr0M17IW9kl6QZ3yO08FvgxRSeg |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEB_0-qBQxG9Xq44gCErofiTZ3ONRLOfZFtEW-hay2SwenHvt7d2Lf5R_o5Ps7uEeWvBxSTaEzNdvMpMZgLeGrCihCMvSIhWMWxLFwgjH8owLRRad89Ct4fRMTi_47FJcdu-4mz7bvQ9JBk0dxFrJw8ZbJu_9CkYwI2HyNuwpAiN8BHuTyezbbBs8IB5MuwDmX38cmKBdRfyHJdrNktwJlQYLdHwf7nXQESctrR_ALVc_hP323g3b50SP4BcJvM8zdyU2xlf-xVb_oKlL3DQOlxVeb0wd3paRpkNfwmnVOLb2RqtXIfjl6CvSoeM83Dk4vFr5gE4YogUWPpmDrZcspL3jvF6GS0Rs5j8dfWGX_76gTYQegPjDkAM9N9inftXYtPmLj-Hi-OP50ZR1PRmYFTxdM1kUFbcVz8dpHru4jDPhSiMteW5O2Liw3OYqS0TukadKuYlLQSsTzkkdqYZx9gRG9bJ2zwDLiuBKQUu4XPCyIle8NIm0ZmyUzMpxHEHck0nbrmC575ux0MFxUVK3lNVEWe0pq2UE77e_XLXVOm6a_M7TXntJpnWt6R4k0O58TSw98R3ScwJ0IoKDwUySQDsYftNzj_ZDPm2tdstNoxMpY54Qy6ub5uRcKkWwMoKnLcdt9054lI45yyLIB7y4neCLgw9H6vn3UCScgKEPkUbwoeda3Wmn5t9H8vy_Zr-GO9Pz0xN98uns8wu4mwYJS1iqDmC0Xm3cS4Jr6-JVJ56_AV7IO20 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3ri9QwEA96gggivq2eGkEQlHB9JGn247G6nK_jEA_uW0jTFAtrum67X_yj_BudSdrFXfTAjyVpCJnXbzKTGUJeGrCigCIsy6tcMG5BFCsjHCsLLhRYdM5Dt4bPp_LknH-4EBdjn9N-ynafQpLxTQNWafLD0apuoogredSjlUJPWDCAHBmTV8k1jpYPo7Vyvg0jADfmYyjzr7_tGKN9lfyHTdrPl9wLmgZbtLhNbo0gkh5Hqt8hV5y_S27GGzgaHxbdI79A9DHj3NW0N1gDmEZNRI2v6aZ3tGvoj43x4ZUZ6DyKxZzWvWMDmq9JmdCz-RcKx0_bcPvg6GqNoZ0wBAssMa2DDR0LCfC09V24TqR9-9PBFx0z4ZewidANkH434Eq3hk5JYJ72MZPxPjlfvPs6P2FjdwZmBc8HJquq4bbh5SwvU5fWaSFcbaQFH84Jm1aW21IVmSgRg6qcm7QWsDIgntyBkpgVD8iB77x7RGjdAHCpYAlXCl434JTXJpPWzIySRT1LE5JOZNJ2LF2OHTSWOrgwSupIWQ2U1UhZLRPyevvLKtbtuGzyK6S9RpmGda0ZnybA7rA6lj7GXuklQDuRkMOdmSCLdmf4xcQ9Gocwgc27btPrTMqUZ8D86rI5JZdKAcBMyMPIcdu9AzKFYy6KhJQ7vLidgGXCd0d8-y2UCweIiMHShLyZuFaPeqr_95E8_q_Zz8n1s7cL_en96ccn5EYeBCxjuTokB8N6454CbhuqZ0E2fwNEvj5D |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+sample+volume+and+use+of+quantitative+reverse-transcription+PCR+can+improve+prediction+of+liver-to-blood+inoculum+size+in+controlled+human+malaria+infection+studies&rft.jtitle=Malaria+journal&rft.au=Hodgson%2C+Susanne+H&rft.au=Douglas%2C+Alexander+D&rft.au=Edwards%2C+Nick+J&rft.au=Kimani%2C+Domtila&rft.date=2015-01-28&rft.pub=BioMed+Central&rft.eissn=1475-2875&rft.volume=14&rft_id=info:doi/10.1186%2Fs12936-015-0541-6&rft_id=info%3Apmid%2F25627033&rft.externalDocID=PMC4318195 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1475-2875&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1475-2875&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1475-2875&client=summon |